Loading...
Loading...
The Vetr community has upgraded Valeant Pharmaceuticals Intl Inc VRX from 3 stars to 3.5 stars.
The crowd is overall much more bearish on the name than Wall Street, with a price target of $14.26 compared to analyst consensus $24.58.
See how crowdsourced ratings can help predict the market?
Valeant shares closed at $12.92 Monday.
For the crowd's full analysis of the stock, click here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in